Tuesday 20 April 2021
Home      All news      Contact us      RSS      India
oneindia.com - 2 month ago

India-made Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results

New Delhi, Mar 03: Bharat Biotech s coronavirus vaccine - Covaxin has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the Hyderabad-based company said on Wednesday. The trials involved 25,800 participants and were conducted in partnership with ICMR, the


Latest News
Hashtags:   

India

 | 

Covaxin

 | 

showed

 | 

interim

 | 

efficacy

 | 

Bharat

 | 

Biotech

 | 

Phase

 | 

results

 | 

Sources